Atypical caspi 2+ currents in chromaffin cells from shr and wky rat strains result from the deficient expression of a splice variant of the α1D caspi 2+channel

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 2, 2012, Pages

  Segura Chama, Pedro ^a   Rivera Cerecedo, Claudia V ^b   González Ramírez, Ricardo ^c   Felix, Ricardo ^d   Hernández Guijo, Jesús M ^e   Hernández Cruz, Arturo ^a  

^a Departamento de Neurociencia Cognitiva   (Mexico)

^b INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^c HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^d DEPARTAMENTO DE FÍSICA   (Mexico)

^e INSTITUTO TEÓFILO HERNANDO   (Spain)

Author keywords

Caspi_sup2+spii_sup channel splice variants; Spontaneously hypertensive rats; Wistar kyoto

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; MESSENGER RNA; MIBEFRADIL; NIFEDIPINE; NNC 55 0396; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; (1S,2S) 2 (2 (N ((3 BENZIMIDAZOL 2 YL)PROPYL) N METHYLAMINO)ETHYL) 6 FLUORO 1,2,3,4 TETRAHYDRO 1 ISOPROPYL 2 NAPHTYL CYCLOPROPANECARBOXYLATE DIHYDROCHLORIDE; (1S,2S)-2-(2-(N-((3-BENZIMIDAZOL-2-YL)PROPYL)-N-METHYLAMINO)ETHYL)-6-FLUORO-1,2,3,4-TETRAHYDRO-1-ISOPROPYL-2-NAPHTYL CYCLOPROPANECARBOXYLATE DIHYDROCHLORIDE; BENZIMIDAZOLE DERIVATIVE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL STIMULATING AGENT; CYCLOPROPANE DERIVATIVE; ISOPROTEIN; NAPHTHALENE DERIVATIVE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CURRENT; CHROMAFFIN CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ELECTROPHYSIOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; WISTAR KYOTO RAT; ANIMAL; CELL STRAIN HEK293; DRUG EFFECT; GENETICS; METABOLISM;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANIMALS; BENZIMIDAZOLES; CALCIUM; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CHROMAFFIN CELLS; CYCLOPROPANES; HEK293 CELLS; HUMANS; MALE; NAPHTHALENES; NIFEDIPINE; PROTEIN ISOFORMS; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 84855310098     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00849.2011     Document Type: Article

References (42)

1. Alviña K, Ellis-Davies G, Khodakhah K. T-type calcium channels mediate rebound firing in intact deep cerebellar neurons. Neuroscience 158: 635-641, 2009.
2. Baldelli P, Hernández-Guijo JM, Carabelli V, Novara M, Cesetti T, Andrés-Mateos E, Montiel C, Carbone E. Direct and remote modulation of L-channels in chromaffin cells: distinct actions on alpha1C and alpha1D subunits? Mol Neurobiol 29: 73-96, 2004.
3. Barbara JG, Poncer JC, McKinney RA, Takeda K. An adrenal slice preparation for the study of chromaffin cells and their cholinergic innervation. J Neurosci Methods 80: 181-189, 1998.
4. Bell DC, Butcher AJ, Berrow NS, Page KM, Brust PF, Nesterova A, Stauderman KA, Seabrook GR, Nürnberg B, Dolphin AC. Biophysical properties, pharmacology, and modulation of human, neuronal L-type (α1D, CaV1.3) voltage-dependent calcium currents. J Neurophysiol 85: 816-827, 2001.
5. Benavides A, Calvo S, Tornero D, González-García C, Ceña V. Adrenal medulla calcium channel population is not conserved in bovine chromaffin cells in culture. Neuroscience 128: 99-109, 2004.
6. Carabelli V, Marcantoni A, Comunanza V, de Luca A, Diaz J, Borges R, Carbone E. Chronic hypoxia up-regulates α1H T-type channels and low threshold catecolamine secretion in rat chromaffin cells. J Physiol 584: 149-165, 2007.
7. Carbone E, Lux HD. A low voltage-activated, fully inactivating calcium channel in vertebrate sensory neurons. Nature 310: 501-502, 1984.
8. 2+ on the blocking/unblocking of human CaV3 channels. J Membr Biol 207: 91-105, 2005.
9. Gandía L, Borges R, Albillos A, García AG. Multiple calcium channel subtypes in isolated rat chromaffin cells. Pflügers Arch 430: 55-63, 1995.
10. García AG, García de Diego AM, Gandía L, Borges R, García-Sancho J. Calcium signaling and exoctytosis in adrenal chromaffin cells. Physiol Rev 86: 1093-1131, 2006.
11. 2+ channels by endogenously released ATP and opioids: from the isolated chromaffin cell to the slice of adrenal medullae. Cell Mol Neurobiol 30: 1209-1216, 2010.
12. Hernández A, Segura-Chama P, Jiménez N, García AG, Hernández- Guijo JM, Hernández-Cruz A. Modulation by endogenously released ATP and opioids of chromaffin cell calcium channels in mouse adrenal slices. Am J Physiol Cell Physiol 300: C610-C623, 2011.
13. Hernández-Guijo JM, de Pascual R, García AG, Gandía L. Separation of calcium channel current components in mouse chromaffin cells superfused with low- and high-barium solutions. Pflügers Arch 436: 75-82, 1998.
14. Hernández-Guijo JM, Carabelli V, Gandia L, Garcia AG, Carbone E. Voltage-independent autocrine modulation of L-type channels mediated by ATP, opioids and catecholamines in rat chromaffin cells. Eur J Neurosci 11: 3574-3584, 1999.
15. Huang L, Keyser BM, Tagmose TM, Hansen JB, Taylor JT, Zhuang H, Zhang M, Ragsdale DS, Li M. NNC 55-0396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1 isopropyl-2-naphthyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels. J Pharmacol Exp Ther 309: 193-199, 2004.
16. Kurtz TW, Morris RC Jr. Biological variability in Wistar-Kyoto rats. Implications for research with the spontaneously hypertensive rat. Hypertension 10: 127-131, 1987.
17. Lim DY, Jang SJ, Park DG. Comparison of catecholamine release in the isolated adrenal glands of SHR and WKY rats. Auton Autacoid Pharmacol 22: 225-232, 2002.
18. Lipscombe D, Helton TD, Xu W. L-type calcium channels: the low down. J Neurophysiol 92: 2633-2641, 2004.
19. -ΔΔCt method. Methods 25: 402-408, 2001.
20. Louis WJ, Howe LG. Genealogy of the spontaneously hypertensive rat and Wistar-Kyoto rat strains: implications for studies of inherited hypertension. J Cardiovasc Pharmacol 16, Suppl 7: S1-S5, 1990.
21. Mahapatra S, Marcantoni A, Vandael DH, Striessnig J, Carbone E. Are Ca(v)1.3 pacemaker channels in chromaffin cells? Possible bias from resting cell conditions and DHP blockers usage. Channels (Austin) 5: 219-224, 2011.
22. Marcantoni A, Baldelli P, Hernandez-Guijo JM, Comunanza V, Carabelli V, Carbone E. L-type calcium channels in adrenal chromaffin cells: role in pace-making and secretion. Cell Calcium 42: 397-408, 2007.
23. Marcantoni A, Carabelli V, Comunanza V, Hoddah H, Carbone E. Calcium channels in chromaffin cells: focus on L and T types. Acta Physiol (Oxf) 192: 233-246, 2008.
24. Marcantoni A, Vandael DH, Mahapatra S, Carabelli V, Sinnegger-Brauns MJ, Striessnig J, Carbone E. Loss of CaV1.3 channels reveals the critical role of L-type and BK channel coupling in pacemaking mouse adrenal chromaffin cells. J Neurosci 30: 491-504, 2010.
25. McAuley JD, Stewart AL, Webber ES, Cromwell HC, Servatius RJ, Pang KC. Wistar-Kyoto rats as an animal model of anxiety vulnerability: upport for a hypervigilance hypothesis. Behav Brain Res 204: 162-168, 2009.
26. McDonald TF, Pelzer S, Trautwein W, Pelzer DJ. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol Rev 74: 365-507, 1994.
27. Miranda-Ferreira R, de Pascual R, de Diego AM, Caricati-Neto A, Gandía L, Jurkiewicz A, García AG. Single-vesicle catecholamine release has greater quantal content and faster kinetics in chromaffin cells from hypertensive, compared with normotensive, rats. J Pharmacol Exp Ther 324: 685-693, 2008.
28. Miranda-Ferreira R, de Pascual R, Caricati-Neto A, Gandía L, Jurkiewicz A, García AG. Role of the endoplasmic reticulum and mitochondria on quantal catecholamine release from chromaffin cells of control and hypertensive rats. J Pharmacol Exp Ther 329: 231-240, 2009.
29. Novara M, Baldelli P, Cavallari D, Carabelli V, Giancippoli A, Carbone E. Exposure to cAMP and -adrenergic stimulation recruits CaV3 T-type channels in rat chromaffin cells through Epac cAMPreceptor proteins. J Physiol 558: 433-449, 2004.
30. Nowycky MC, Fox AP, Tsien RW. Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature 316: 440-443, 1985.
31. Okamoto K. Spontaneous hypertension in rats. Int Rev Exp Pathol 7: 227-270, 1969.
32. Pare WP. Stress ulcer susceptibility and depression in Wistar Kyoto (WKY) rats. Physiol Behav 46: 993-998, 1989.
33. Pare WP. Open field, learned helplessness, conditioned defensive burying, and forced-swim tests in WKY rats. Physiol Behav 55: 433-439, 1994.
34. Pérez-Alvarez A, Hernández-Vivanco A, Caba-González JC, Albillos A. Different roles attributed to Cav1 channel subtypes in spontaneous action potential firing and fine tuning of exocytosis in mouse chromaffin cells. J Neurochem 116: 105-121, 2011.
35. 2+ channels in rat chromaffin cells. J Neurophysiol 81: 2267-2278, 1999.
36. Rae J, Cooper K, Gates P, Watsky M. Low access resistance perforated patch recordings using amphotericin B. J Neurosci Methods 37: 15-26, 1991.
37. Rittenhouse PA, Lopez-Rubalcava C, Stanwood GD, Lucki I. Amplified behavioral and endocrine responses to forced swim stress in the Wistar-Kyoto rat. Psychoneuroendocrinology 27: 303-318, 2002.
38. Sakaguchi A, LeDoux JE, Reis DJ. Sympathetic nerves and adrenal medulla: contributions to cardiovascular conditioned emotional responses in spontaneously hypertensive rats. Hypertension 5: 728-738, 1983.
39. Segura-Chama P, Hernández A, Jiménez-Pérez N, Alejandre-García T, Rivera-Cerecedo CV, Hernández-Guijo JM, Hernández-Cruz A. Comparison of Ca2+ currents of chromaffin cells from normotensive Wistar Kyoto and spontaneously hypertensive rats. Cell Mol Neurobiol 30: 1243-1250, 2010.
40. Seto SW, Docherty JR. Effects of T-type calcium channel blockers and thalidomide on contractions of rat vas deferens. Br J Pharmacol 159: 1211-1216, 2010.
41. Singh A, Gebhart M, Fritsch R, Sinnegger-Brauns MJ, Poggiani C, Hoda JC, Engel J, Romanin C, Striessnig J, Koschak A. Modulation of voltage- and Ca2+-dependent gating of CaV1.3 L-type calcium channels by alternative splicing of a C-terminal regulatory domain. J Biol Chem 283: 20733-20744, 2008.
42. 2+ channels. Cell Calcium 40: 97-114, 2006.